Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: A systematic review and meta-analysis Review


Authors: Woo, S.; Ghafoor, S.; Becker, A. S.; Han, S.; Wibmer, A. G.; Hricak, H.; Burger, I. A.; Schöder, H.; Vargas, H. A.
Review Title: Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: A systematic review and meta-analysis
Abstract: Purpose: Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has shown promise for detecting nodal and distant prostate cancer (PCa) metastases. However, its performance for local tumor staging is not as well established. The purpose of this study was to review the diagnostic performance of PSMA-PET for determining seminal vesical invasion (SVI) and extraprostatic extension (EPE). Methods: Pubmed and Embase databases were searched until January 12, 2020. Studies assessing accuracy of PSMA-PET in determining SVI and EPE were included. Study quality was evaluated with the revised Quality Assessment of Diagnostic Accuracy Studies-2 tool. Pooled sensitivity and specificity were calculated using hierarchical summary receiver operating characteristics modeling. Heterogeneity was explored using meta-regression analyses for anatomical imaging component (MRI vs CT) and by testing for a threshold effect. Results: Twelve studies (615 patients) were included. Pooled sensitivity and specificity were 0.68 (95% CI 0.53-0.81) and 0.94 (95% CI 0.90-0.96) for SVI and 0.72 (95% CI 0.56-0.84) and 0.87 (95% CI 0.72-0.94) for EPE. Meta-regression analyses showed that for SVI, PET/MRI demonstrated greater sensitivity than PET/CT (0.87 [95% CI 0.75-0.98] vs 0.60 [95% CI 0.47-0.74]; p = 0.02 for joint model) while specificity was comparable (0.91 [95% CI 0.84-0.97] vs. 0.96 [95% CI 0.93-0.99]) but not for EPE (p = 0.08). A threshold effect was present for studies assessing EPE (correlation coefficient = 0.563 [95% CI, −0.234-0.908] between sensitivity and false-positive rate). Conclusion: PSMA-PET has moderate sensitivity and excellent specificity for assessing local tumor extent in patients with PCa. PET/MRI showed potential for greater sensitivity than PET/CT in assessing SVI. © 2020, The Author(s).
Keywords: positron emission tomography; magnetic resonance imaging; prostate cancer; computed tomography; meta-analysis; prostate-specific membrane antigen
Journal Title: European Journal of Hybrid Imaging
Volume: 4
ISSN: 2510-3636
Publisher: SpringerOpen  
Date Published: 2020-09-09
Start Page: 16
Language: English
DOI: 10.1186/s41824-020-00085-9
PROVIDER: scopus
PMCID: PMC8218057
PUBMED: 34191215
DOI/URL:
Notes: Article -- Export Date: 1 March 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Heiko Schoder
    551 Schoder
  2. Hedvig Hricak
    421 Hricak
  3. Andreas Georg Wibmer
    54 Wibmer
  4. Soleen Ghafoor
    17 Ghafoor
  5. Sungmin Woo
    62 Woo
  6. Anton Sebastian Becker
    40 Becker